We are now offering a new treatment option for tinnitus in our clinics – Lenire®.

Lenire is a treatment device that has been proven in large-scale clinical trials to reduce tinnitus symptoms. It uses bimodal neuromodulation to drive long-term changes in the brain to treat tinnitus.

What is Lenire?
Lenire is a treatment device that has been proven in large-scale clinical trials to reduce the symptoms of tinnitus. It uses bimodal neuromodulation to drive long-term changes in the brain to treat tinnitus.

How does it work?
The treatment plays sounds from headphones and provides gentle electrical stimulation to the tongue via a Tonguetip. The sounds and electrical stimulation work together to retrain your brain. You pay less attention to your tinnitus reducing its impact on your day-to-day life. Lenire is used as part of a treatment plan prescribed and supervised by a qualified healthcare professional. The settings are customised to suit your tinnitus after an assessment to make sure you’re suitable.

What is the evidence behind Lenire?
• More than 500 people participated in two large-scale clinical trials proving Lenire can reduce the severity of tinnitus symptoms

• The first of these trials, published in 2020, was one of the largest and longest followed-up trials of a tinnitus device. It showed that 86.2% of treatment-compliant participants achieved an improvement in their tinnitus symptoms after 12 weeks of treatment

• 80.1% of treatment-compliant participants achieved an improvement which sustained for at least 12 months after treatment ended 

• The second large-scale trial, published in 2022, optimised treatment with Lenire and showed better results

• 95% of treatment-compliant participants reported an improvement in their symptoms after 12 weeks of treatment 1,3 o 91% of treatment-compliant participants reported an improvement in their symptoms which lasted at least 12 months after treatment ended 

• An independent analysis of real-world patients from Germany, published in early 2022, showed consistent results with clinical trials after six to 12 weeks of treatment

How can I get started?
We’re a certified provider of treatment of tinnitus with Lenire. Get in touch today for further information or to book an assessment for Lenire. 

*Please note*
Lenire is not suitable for all patients. Tinnitus management is not a one-size-fits-all approach and appropriate pathways are individual to each patient. Please contact us to find put more at hello@gatwickaudiology.co.uk or call 0333 011 7717.

1. As measured by THI
2. Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020)
3. Conlon et al., Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial,
   Sci Rep, https://www.nature.com/articles/s41598-022-13875-x (2022)
4. Buechner A, Lesinski-Schiedat A, Becker P, Lenarz T, Real-world clinical experience with bimodal
   neuromodulation for the treatment of tinnitus – A case series, Brain Stimulation (2022
   https://www.lenire.com/